Valletta · Seed–Growth
Investment thesis
Elevat3 Capital takes a hands-on, high value-add approach as a long-term partner to portfolio companies. Its investment philosophy centers on the belief that every company has one to three 'triggers' at any stage that, if executed well, can move it to the next valuation level; the firm targets companies where it can influence or control these triggers. As the venture arm of Apeiron Investment Group, Elevat3 focuses on leading venture deals in Europe, backing high-growth technology companies, and benefits from Apeiron's largely proprietary capital base which enables an entrepreneurial and flexible posture.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 5 of 6 portfolio companiesBiotech ×2PropTech ×2Advanced Manufacturing ×1Construction Tech ×1Healthtech ×1Impact & Social Good ×1InsurTech ×1Longevity ×1
HQs:Germany×4United States×1
Investments · 6 tracked
founders shown can be your intro pathAmyriAD Therapeutics is developing Ismidenon (formerly AD101), a once-daily oral small molecule therapy intended to improve cognition and function in patients with Alzheimer's disease.
BiotechLongevity
Co-investorsWhat If Ventures
GROPYUS designs and builds multi-family residential buildings using technology-enabled prefabrication and robotics, delivering affordable housing with optimized planning, manufacturing, assembly, and digital building management.
Advanced ManufacturingConstruction TechPropTechBerlin, DE
Markus Fuhrmann(Co-CEO, Founder)Philipp Erler(Co-CEO, Founder)
Co-investorsManta Ray VenturesNovaco InvestSaxoventSemapa Next
Neodigital is a German property and casualty insurer offering online-managed insurance products including auto, home, liability, pet, accident, and personal goods coverage.
InsurTechGermany, DE
Co-investorsAlstin Capital
Periskop is an investment specialist based in Berlin that develops and advises real estate funds, combining profitable growth with social value creation for institutional investors.
Impact & Social GoodPropTechBerlin, DE
Tiakis develops investigational therapeutics targeting pulmonary-arterial hypertension and postoperative inflammation using tissue-protective mechanisms derived from clinical research.
BiotechHealthtechMedical DevicesKiel, DE
Frequently asked questions
- How many investments has Elevat3 Capital made?
- Elevat3 Capital has 6 tracked investments.
- What stage does Elevat3 Capital invest at?
- Elevat3 Capital invests at the Seed, Series A, Series B, Growth stages.
- What is Elevat3 Capital's typical check size?
- Elevat3 Capital typically writes checks of $5M – $20M.
- What sectors does Elevat3 Capital focus on?
- Elevat3 Capital focuses on Biotech, Crypto & Web3, Deep Tech, Fintech, FoodTech, PropTech.
- Where is Elevat3 Capital located?
- Elevat3 Capital is headquartered in Valletta, MT.
- Does Elevat3 Capital lead rounds?
- Yes, Elevat3 Capital leads investment rounds.
- Who does Elevat3 Capital co-invest with?
- Elevat3 Capital most often shares deals with Alstin Capital, Manta Ray Ventures, Novaco Invest, among 6 tracked co-investors.
Similar investors
Daphni is a venture capital firm investing in early-stage European startups across multiple sectors. The firm focuses on companies with European origins that pursue international growth opportunities.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
INP Capital is a global investment firm that invests across the full company life cycle, from early stage to pre-IPO, seeking to identify and back emerging technology companies as they scale toward unicorn status.
Highline Beta is a venture studio and venture capital firm that co-creates new ventures with corporate partners and co-invests alongside founders. It helps enterprises design, launch, and run corporate venture studios and build new ventures from idea to launch.
2080 Ventures is a global venture ecosystem partner that connects founders, investors, corporates, and governments to accelerate innovation locally and globally, running accelerator programs and offering tools for founders, M&A, and secondaries.